What Is Incidence?
Incidence measures how many new cases of a disease appear in a defined population during a specified time period. It answers the question: "How fast is this disease spreading?" A high incidence means the disease is actively infecting people. Incidence is used to study disease risk, track outbreak speed, and evaluate prevention programs.
Consider a town of 10,000 people. In January, none of them have influenza. By February, 200 residents have been diagnosed with flu for the first time that season. Those 200 new cases are the incidence. They represent the flow of disease into the population from a disease-free state.
Incidence is the go-to measure when you want to understand disease dynamics. It answers questions like: Is this outbreak getting worse? Did the new vaccine reduce new infections? Is this occupational exposure causing new illness? Because it counts only new cases in previously healthy people, it is directly tied to risk — the probability that a person will develop the disease.
Two Types: Cumulative Incidence and Incidence Rate
There are two main ways to express incidence. They answer slightly different questions, and choosing between them depends on the data available and the question being asked.
Cumulative incidence (also called attack rate or risk) is the proportion of a disease-free population that develops the disease over a defined observation period. It assumes everyone in the population is observed for the entire period — a simplification that works well for short time frames or closed populations like military cohorts or school outbreaks.
New cases = people newly diagnosed during the observation period
Population at risk = disease-free people at the start of the period
Multiplier = 1,000 or 100,000 (per standard unit)
Incidence rate (also called incidence density) accounts for the fact that people enter and leave observation at different times. Instead of counting people, the denominator counts person-time — the total time each individual was observed while still disease-free. This makes it appropriate for cohort studies where follow-up lengths vary.
New cases = people newly diagnosed during the study
Person-time = sum of each individual's disease-free observation time
Multiplier = per 1,000 person-years or per 100,000 person-years
People who already have the disease cannot develop it for the first time, so they are excluded from the denominator in incidence calculations. For example, when calculating the incidence of measles, vaccinated individuals who are immune and people already recovering from measles are not part of the "at risk" group. Getting the denominator right is just as important as counting new cases accurately.
What Is Prevalence?
Using the same town of 10,000 people: if you surveyed the entire population on March 1 and found 350 residents currently have influenza — some diagnosed last week, some still recovering from the February wave — that 350 is the prevalence. It is a snapshot of disease load at a single moment.
Prevalence is the measure that tells healthcare planners how many patients need treatment right now. It drives decisions about hospital capacity, medication stockpiles, specialist staffing, and disability services. A disease can have very low incidence but still impose enormous burden if those who develop it live with it for decades.
Point Prevalence
Point prevalence is the most commonly used type. It measures the proportion of a population with the disease at a single, specific moment — a defined calendar date or a single survey day.
Cases = all individuals with the disease on the specified date (new and existing)
Total population = all individuals in the defined group on that date
Multiplier = typically per 1,000 or per 100,000
Period Prevalence
Period prevalence extends the snapshot across a time window. It counts anyone who had the disease at any point during the defined period, including people who were sick at the start, people who got sick during the period, and people who recovered during it. It is wider than point prevalence and useful for conditions that fluctuate — seasonal allergies, depressive episodes, or recurring infections.
Cases = anyone who had the disease at any point during the period
Average population = midpoint population count for the period
Incidence vs. Prevalence: Key Differences
Incidence counts only new cases in a disease-free population over a defined time period. Prevalence counts all existing cases — new and old — at a given point or period. Incidence measures disease risk and spread speed. Prevalence measures total disease burden. For acute illnesses that resolve quickly, incidence is high and prevalence is low. For chronic diseases, prevalence is high relative to incidence because cases accumulate over years.
| Characteristic | Incidence | Prevalence |
|---|---|---|
| What it counts | New cases only — people who were disease-free and then developed the condition | All existing cases — both new diagnoses and people already living with the condition |
| Core question | "How fast is the disease spreading? What is the risk of getting it?" | "How many people have this disease right now? What is the burden?" |
| Formula | New cases / Population at risk × time period | Existing cases / Total population at a point in time |
| Numerator | Only new cases arising during the observation window | All cases present during the measurement period (new + ongoing) |
| Denominator | Population at risk (excludes those already sick or immune) | Total population (all persons in the defined group) |
| Time component | Always tied to a time period (per year, per month, per follow-up) | Point: a single moment; Period: a defined window |
| Primary use | Studying disease risk, transmission, cause, and prevention | Planning healthcare resources, estimating disease burden, policy making |
| Best study design | Cohort studies; outbreak investigations; longitudinal studies | Cross-sectional surveys; population health assessments |
| Acute illness example | High incidence (many new cases each season) but low prevalence (illness resolves in days) | Low prevalence because cases recover quickly and leave the pool |
| Chronic illness example | Lower incidence (fewer new cases per year) relative to the burden | High prevalence because patients accumulate in the pool over decades |
| Interpretation | Tells you about disease dynamics and risk factors | Tells you about current healthcare needs and service demand |
| Relationship formula | — | Prevalence ≈ Incidence × Average disease duration |
News articles regularly swap these terms or report one when they mean the other. A headline reading "500,000 cases of diabetes in this country" is almost always describing prevalence, not incidence. Reading carefully for phrases like "new diagnoses this year" (incidence) vs. "currently living with" or "total cases" (prevalence) protects you from misinterpreting disease statistics.
Why Epidemiologists Use Both Measures
Incidence and prevalence each answer different questions. Using only one produces an incomplete and sometimes misleading picture of disease in a population. Consider what happens when you look at them together:
Disease monitoring. Rising incidence tells you the disease is spreading faster than before — a signal for outbreak investigation. Stable incidence alongside rising prevalence tells you that more people are surviving but remaining ill — a signal to invest in treatment infrastructure rather than prevention alone.
Healthcare planning. Hospital capacity and specialist staffing depend on how many patients need care today — that is prevalence. Vaccine supply calculations and contact tracing programs depend on how many new cases are expected next month — that is incidence. A public health department that only watches one measure will consistently over- or under-prepare for the other dimension of need.
Resource allocation. The relationship between incidence and prevalence reveals something important about how a disease behaves. If prevalence is much larger than incidence × 1 year, the disease is long-lasting. If prevalence is close to the annual incidence figure, the disease resolves quickly. That ratio — duration — tells policymakers whether they need more acute care beds or more long-term care facilities.
Evaluating interventions. A vaccination campaign should drive incidence down first — fewer new cases. Prevalence may lag behind for years because people already living with the condition are still counted. Watching only prevalence could lead officials to conclude a prevention program is not working, even when incidence has already started falling. Both numbers together show the full trajectory.
Research causation. Incidence is the measure used in cohort studies to establish whether a risk factor causes disease. Prevalence studies are faster and cheaper but mix cases of different durations, which can bias results. Epidemiologists calculating risk ratios and hazard ratios work from incidence data, not prevalence figures. The study design guide covers cohort and cross-sectional methods in detail.
How to Calculate Incidence
Step-by-Step: Cumulative Incidence
Calculating the attack rate of a school influenza outbreak
Define the population at risk. A school has 800 students. At the start of the observation week, 50 students are already sick with influenza. The population at risk is 800 − 50 = 750 students (those who are disease-free and could develop flu).
Count new cases during the period. Over the following seven days, 120 of the 750 disease-free students develop influenza for the first time. These 120 are the new cases — the incidence count.
Apply the formula. Cumulative Incidence = 120 / 750 = 0.16. Multiplied by 100, this gives a 7-day attack rate of 16 per 100 students, or 16%.
Interpret the result. A 16% attack rate means that in one week, 16 out of every 100 students who were initially healthy developed influenza. This is a high attack rate for a single week and would typically trigger school closure protocols or urgent vaccination outreach.
✓ Result: Cumulative incidence = 16% over 7 days. This measures the risk of developing influenza among susceptible students during this outbreak period.
Step-by-Step: Incidence Rate Using Person-Time
Calculating the incidence rate of tuberculosis in a cohort study with variable follow-up
Identify participants and observation time. A cohort study follows 1,000 adults for up to 5 years to track tuberculosis. Some participants leave the study early, so follow-up times vary. Person-time at risk is calculated for each individual until they develop TB, leave the study, or the study ends.
Sum person-time at risk. After adding up each participant's disease-free observation time, the total is 4,200 person-years. This figure accounts for the fact that people who left early contributed fewer years of observation than those who stayed the full 5 years.
Count new cases of TB. During the study, 42 participants develop tuberculosis for the first time.
Calculate the incidence rate. Incidence Rate = 42 / 4,200 person-years = 0.01 per person-year = 10 per 1,000 person-years.
Interpret the rate. An incidence rate of 10 per 1,000 person-years means that for every 1,000 people followed for one year, 10 new TB cases would be expected. This rate can be compared across populations, time periods, or subgroups to identify who is at highest risk.
✓ Result: Incidence rate = 10 per 1,000 person-years. Person-time denominators make this rate comparable even when follow-up lengths differ across participants.
How to Calculate Prevalence
Step-by-Step: Point Prevalence
Estimating the point prevalence of hypertension in a city
Choose a point in time. A health department conducts a blood pressure screening survey on a single day in a city of 500,000 adults. This defines the "point" at which prevalence is measured.
Count existing cases at that point. The survey identifies 115,000 adults with hypertension on that day — including those already on medication, those newly diagnosed during screening, and those previously diagnosed but untreated.
Apply the formula. Point Prevalence = 115,000 / 500,000 = 0.23. Multiplied by 100, this gives a point prevalence of 23% (or 230 per 1,000 adults).
Interpret the result. A prevalence of 23% means that on this specific day, 23 out of every 100 adults in the city had hypertension. This figure tells city health planners how many patients currently need antihypertensive medication, primary care monitoring, or cardiovascular risk management.
✓ Result: Point prevalence = 23% on survey day. This figure drives healthcare resource planning — not risk estimation, which would require incidence data.
The Prevalence-Incidence Relationship
One of the most useful relationships in epidemiology connects the three key quantities of disease measurement:
This formula reveals why chronic diseases dominate prevalence statistics. A condition with an incidence rate of 50 per 100,000 per year and an average duration of 20 years generates a prevalence of approximately 1,000 per 100,000 — that is, 1% of the population. A disease with the same incidence but lasting only one week has a prevalence of roughly 1 per 100,000 at any given moment. Duration drives prevalence far more than transmission rate does.
Real Example: COVID-19 Surveillance
The COVID-19 pandemic provided some of the most publicly visible examples of incidence and prevalence data in history. Health agencies worldwide published both measures, often without explaining the difference — which led to significant public confusion.
How incidence and prevalence told different stories during the pandemic
Incidence data: tracking new infections. Daily case counts reported by governments represented a form of incidence — new confirmed infections each day. The WHO situation reports published new weekly case counts by country. When these daily figures rose steeply, it signaled accelerating transmission — an incidence signal that prompted lockdowns and travel restrictions.
Prevalence data: estimating total burden. Because many COVID-19 cases were asymptomatic or untested, official case counts understated true prevalence. Serology surveys — blood tests checking for antibodies — gave a better estimate of how many people had ever been infected. These surveys measured a form of cumulative prevalence, revealing that true infection rates were often 5–20 times higher than confirmed case counts suggested.
The active case count: a snapshot of prevalence. "Active cases" — people currently infected — was a point prevalence measure. Hospital capacity planning depended on this figure, not on cumulative case counts. A country with 1 million cumulative cases over six months had a very different healthcare burden depending on whether those cases were spread evenly or concentrated in a two-week surge.
Public health interpretation. Falling incidence (fewer new daily cases) while active case counts (prevalence) remained high told health officials that the outbreak had peaked but hospitals were still under pressure. This is exactly when lifting restrictions prematurely causes a second wave — the prevalence burden has not yet cleared even though the incidence trend is improving.
✓ Lesson: Incidence tracked the pandemic's speed. Prevalence tracked its current weight on the healthcare system. Both were essential — neither alone was sufficient for public health decision-making.
Real Example: Diabetes Statistics
Type 2 diabetes is the textbook illustration of how chronic diseases produce high prevalence relative to incidence. Understanding both measures changed how governments fund diabetes care.
Why diabetes prevalence continues rising even as incidence stabilizes in some countries
The incidence picture. According to the World Health Organization, the global incidence of diabetes has been rising for decades, though some high-income countries have seen age-standardized incidence rates plateau or fall slightly since the 2010s. This reflects modest success in prevention programs targeting diet, physical activity, and obesity — the main modifiable risk factors.
The prevalence picture — and why it keeps rising. The International Diabetes Federation estimates that over 500 million adults worldwide currently live with diabetes — a prevalence figure that has grown consistently even where incidence has leveled off. The reason is survival. Improved treatments — metformin, insulin analogues, SGLT-2 inhibitors — mean people with diabetes live longer. Each year's new cases (incidence) join millions already in the prevalence pool, and fewer people die early from the disease.
Healthcare planning implication. If planners used only incidence trends and saw stabilization, they might assume diabetes burden is leveling off. But prevalence tells the real story: the number of people needing dialysis, ophthalmology appointments, foot care, and cardiovascular management keeps growing. Prevention (a response to incidence) and treatment capacity (a response to prevalence) both require separate, sustained investment.
✓ Lesson: Stable incidence alongside rising prevalence is the signature of a chronic disease where treatment has improved survival. Both numbers together reveal a healthcare system that is succeeding at keeping patients alive but must plan for a growing long-term burden.
Real Example: Influenza Outbreak Investigation
Outbreak investigation is where incidence calculation is most time-sensitive. Epidemiologists at agencies like the CDC and the European Centre for Disease Prevention and Control (ECDC) calculate attack rates as the primary measure of how fast an outbreak is moving and whether containment is working.
Attack rate calculation and outbreak control in a residential care facility
Establish the population at risk. A residential care facility houses 200 elderly residents and employs 80 staff. At the start of an influenza outbreak investigation, 12 residents are already sick. The population at risk is 200 − 12 + 80 = 268 people who are currently well and could develop flu.
Count new cases over 5 days. By day 5, 54 residents and 8 staff who were previously well have developed influenza-like illness — 62 new cases in total.
Calculate the 5-day attack rate. Cumulative Incidence (Attack Rate) = 62 / 268 = 0.231 = 23.1% over 5 days. This is a high attack rate, suggesting effective person-to-person transmission in a closed setting.
Interpret for outbreak control. A 23% attack rate in 5 days in a closed elderly population is serious. Public health officials would initiate antiviral prophylaxis (oseltamivir) for remaining susceptible residents, implement cohorting of sick patients, and investigate the index case. Vaccination status of residents and staff would be checked against attack rates to estimate vaccine effectiveness.
✓ Result: 5-day attack rate = 23.1%. Incidence data drives the outbreak response — identifying who is getting sick fastest, where transmission is occurring, and whether control measures are reducing the rate of new cases.
Factors That Affect Incidence and Prevalence
Incidence and prevalence do not always move together, and they can move in opposite directions for entirely logical reasons. Understanding what drives each measure is essential for interpreting changes in disease statistics correctly.
| Factor | Effect on Incidence | Effect on Prevalence | Example |
|---|---|---|---|
| Effective vaccination program | Decreases — fewer susceptible people develop the disease | Decreases — fewer new cases enter the prevalence pool | Measles incidence and prevalence both fell dramatically after mass vaccination campaigns |
| Improved treatment (higher survival) | Little direct effect on new cases | Increases — patients live longer with the disease and remain in the prevalence count | HIV antiretroviral therapy dramatically increased HIV prevalence even as incidence fell in some regions |
| Improved diagnostics / screening | Apparent increase — more cases are found that existed before but were undetected | Apparent increase for same reason | Expanded PSA screening for prostate cancer appeared to increase both incidence and prevalence during rollout |
| Disease becoming more fatal | No direct effect on new case generation | Decreases — patients die sooner, leaving the prevalence pool faster | Highly virulent infectious disease outbreaks can reduce prevalence rapidly through mortality |
| Population migration | May increase if migrants are susceptible; decrease if migrants are immune | Changes based on disease prevalence in the migrant population | Tuberculosis prevalence in receiving countries changes with migration patterns from high-prevalence regions |
| Spontaneous recovery (acute disease) | Not directly affected | Decreases as people recover and leave the case count | Influenza prevalence drops quickly after a season peak even while annual incidence accumulates |
| Risk factor exposure increases | Increases as more people are exposed to the cause of disease | Eventually increases as more cases accumulate | Rising obesity rates drove increasing diabetes incidence and, over time, higher prevalence |
When a disease is in steady state — incidence roughly balanced by recovery and death — Prevalence ≈ Incidence Rate × Average Duration holds approximately. This formula is useful for estimating the quantity you do not have when you know the other two. If you know diabetes incidence is 7 per 1,000 per year and average disease duration is 18 years, estimated prevalence is approximately 7 × 18 = 126 per 1,000, or about 12.6% — consistent with observed figures in many high-income countries.
Common Mistakes When Interpreting Incidence and Prevalence
| Mistake | Why It Matters | The Correct Interpretation |
|---|---|---|
| Using "cases" without specifying new or existing | The word "cases" is meaningless without knowing whether it refers to new diagnoses (incidence) or total people currently sick (prevalence). Media reports often omit this distinction entirely. | Always clarify: "new cases reported this week" = incidence. "Total people living with the condition" = prevalence. Require this precision when reading or writing disease statistics. |
| Assuming high prevalence means high transmission | A disease can have high prevalence but low incidence if it is long-lasting. Arthritis affects millions but spreads through aging and genetics, not person-to-person contact. High prevalence does not mean the disease is highly infectious. | High incidence is the signal of rapid transmission. High prevalence alongside low incidence signals chronicity and/or high survival — two very different public health situations requiring different responses. |
| Ignoring the time period in incidence figures | An incidence rate of 50 per 100,000 per year and 50 per 100,000 per month describe radically different disease speeds. Without the time unit, comparison across studies is impossible. | Incidence is always paired with a defined time period. When comparing incidence across studies or populations, verify that the time windows are identical before drawing conclusions. |
| Using the wrong denominator for incidence | Including already-sick people in the denominator of an incidence calculation understates the true risk. If 10% of a population already has a chronic disease, the true at-risk population is 90%, not 100%. | The denominator for incidence must be the population at risk — people who are susceptible and could develop the disease. Excluding immune, already-affected, or ineligible individuals is not optional. |
| Concluding that a prevention program failed because prevalence did not fall immediately | For chronic diseases, prevalence continues rising even after successful prevention reduces incidence, because existing cases remain in the prevalence count for years. Judging a prevention program by short-term prevalence trends will almost always give a falsely pessimistic result. | Prevention programs reduce incidence first. Prevalence follows slowly, with a lag proportional to disease duration. Evaluate prevention success by tracking incidence trends, not prevalence. Both matter, but on different timescales. |
| Comparing raw case counts across populations of different sizes | Country A reporting 10,000 new cases and Country B reporting 5,000 new cases does not mean Country A has a worse outbreak if Country A has ten times the population. Raw counts without rates are not comparable. | Convert counts to rates per 1,000 or per 100,000 before comparing across populations. A rate adjusts for population size and makes comparison meaningful. The study design guide covers rate standardization in more detail. |
Frequently Used Epidemiological Measures
Incidence and prevalence belong to a broader toolkit of measures used to describe and compare disease in populations. Knowing when to use each one prevents analytical errors and ensures the right question is being answered.
| Measure | Definition | When to Use | Formula |
|---|---|---|---|
| Incidence Rate | New cases per unit of person-time at risk | Cohort studies, time-varying risk, comparing populations with different follow-up | New cases / Person-time at risk |
| Cumulative Incidence | Proportion of at-risk people who develop disease over a period | Closed populations, short time frames, outbreak investigation | New cases / Population at risk |
| Point Prevalence | Proportion with disease at a specific moment | Cross-sectional surveys, resource planning, burden estimation | Existing cases at time point / Total population |
| Period Prevalence | Proportion who had disease at any point in a window | Episodic conditions, mental health, seasonal diseases | Cases during period / Average population |
| Mortality Rate | Deaths from a cause per population per unit time | Measuring disease severity, comparing treatment effectiveness | Deaths / Population × time |
| Case Fatality Rate (CFR) | Proportion of diagnosed cases who die from the disease | Measuring how lethal a disease is among those who have it | Deaths / Confirmed cases |
| Attack Rate | Proportion of exposed people who develop disease during an epidemic | Outbreak investigation, estimating transmissibility | New cases / Population exposed |
| Risk Ratio (Relative Risk) | Ratio of incidence in exposed vs. unexposed groups | Cohort studies; measuring strength of association between risk factor and disease | Incidence in exposed / Incidence in unexposed |
| Odds Ratio | Ratio of odds of disease in exposed vs. unexposed | Case-control studies; rare diseases; logistic regression output | (Cases exposed / Controls exposed) ÷ (Cases unexposed / Controls unexposed) |
Epidemiological Statistics Decision Guide
Choosing the right measure starts with knowing what question you are trying to answer. The decision framework below maps research objectives to the appropriate measure.
Define the objective
Are you measuring disease risk, disease burden, or the strength of a risk factor association? Each objective maps to a different class of measure.
Identify the time frame
Point-in-time measurement → prevalence. Over a defined period with new case counting → incidence. The time element determines which formula applies.
Choose the study design
Cohort study → incidence rate or cumulative incidence. Cross-sectional survey → point prevalence. Case-control study → odds ratio (not incidence directly).
Check the denominator
Incidence: population at risk only. Prevalence: total defined population including those already ill. Wrong denominators are the most common calculation error.
Report with context
State the time period, population, and multiplier used. A prevalence of 230 per 1,000 adults in urban areas aged 45–65 is a complete statement. "Prevalence is 23%" is not.
Use both when planning
Incidence for prevention programs. Prevalence for treatment capacity. Public health planning requires both — routinely reporting only one creates blind spots in resource allocation.
| Research Objective | Appropriate Measure | Example Disease | Recommended Study Design |
|---|---|---|---|
| Estimate the risk of developing disease in a population | Cumulative incidence | Influenza, COVID-19, foodborne illness | Cohort study; outbreak investigation |
| Compare transmission speed across countries or regions | Incidence rate per person-time | Tuberculosis, HIV, hepatitis | Prospective cohort; national surveillance |
| Estimate how many patients need treatment right now | Point prevalence | Diabetes, hypertension, depression | Cross-sectional survey; national health survey |
| Plan hospital capacity or specialist staffing | Point or period prevalence | Chronic kidney disease, cancer | Health records analysis; population registry |
| Evaluate whether a prevention program reduced disease risk | Incidence rate comparison before and after | Measles (post-vaccination), lung cancer (post-smoking policy) | Interrupted time series; before-after cohort |
| Study whether a risk factor causes disease | Risk ratio from incidence data | Smoking and lung cancer, obesity and diabetes | Cohort study; randomized controlled trial |
| Measure disease burden for health policy | Both incidence and prevalence | Any chronic condition | National disease registry; population surveillance |
Incidence vs. Prevalence Cheat Sheet
| Concept | Incidence | Prevalence |
|---|---|---|
| What it measures | New cases in disease-free people over a time period | All existing cases (new + ongoing) at a point or period |
| Core question | How fast is the disease spreading? What is the risk? | How many people have the disease right now? |
| Numerator | New cases only — must not have had disease before observation | All current cases — anyone with the disease at the measurement point |
| Denominator | Population at risk (susceptible, disease-free) | Total population in the defined group |
| Time dependency | Always expressed per unit of time (year, month, observation period) | Point: single moment. Period: defined window (month, year) |
| Cumulative Incidence formula | New cases / Population at risk × multiplier | — |
| Incidence Rate formula | New cases / Person-time at risk × multiplier | — |
| Point Prevalence formula | — | Cases at time point / Total population × multiplier |
| Period Prevalence formula | — | Cases during period / Average population × multiplier |
| Relationship | Prevalence ≈ Incidence Rate × Average Disease Duration (at steady state) | |
| Acute disease behavior | High incidence during outbreak seasons | Low prevalence — cases recover quickly |
| Chronic disease behavior | Lower annual incidence relative to burden | High prevalence — cases accumulate over decades |
| Primary study design | Cohort study; outbreak investigation; longitudinal study | Cross-sectional survey; population health assessment |
| Key application | Prevention programs, vaccine evaluation, transmission studies | Healthcare planning, resource allocation, policy making |
| What reduces it | Vaccination, risk factor reduction, quarantine | Lower incidence + shorter disease duration + higher case fatality |
| COVID-19 equivalent | Daily new confirmed cases; weekly case counts | Active cases; serology-based population infection estimates |
| Diabetes equivalent | New diagnoses per year per 1,000 adults | Total adults currently living with diabetes per 1,000 |
Epidemiology Glossary
Every term used in this guide and in standard epidemiological literature is defined below for quick reference. This glossary is designed to serve as a standalone citation resource for students, educators, and researchers.
| Term | Definition | Context / Notes |
|---|---|---|
| Incidence | The number or proportion of new cases of a disease arising in a defined population during a specified time period | Measures disease risk and transmission speed; used in cohort studies and outbreak investigation |
| Prevalence | The proportion of a defined population that has a specific disease or condition at a given point or period in time | Includes new and existing cases; measures disease burden; drives healthcare resource planning |
| Incidence Rate | The number of new cases divided by the total person-time at risk during the observation period | Expressed per 1,000 or 100,000 person-years; adjusts for variable follow-up times in cohort studies |
| Cumulative Incidence | The proportion of a disease-free population that develops the disease over a defined observation period; also called risk or attack rate | Assumes everyone is observed for the full period; valid for closed populations or short time frames |
| Point Prevalence | The proportion of a population with the disease at a specific, defined point in time | A snapshot measure; most commonly reported prevalence type; drives short-term resource planning |
| Period Prevalence | The proportion who had the disease at any point during a defined time window, including those ill at the start | Broader than point prevalence; useful for episodic or seasonal conditions |
| Population at Risk | The group of people who are susceptible to developing the disease and are therefore eligible to contribute to the incidence numerator | Excludes people already ill, immune, or otherwise ineligible; forms the denominator in incidence calculations |
| Person-Time | The sum of the time each individual in a study spent under observation while disease-free; the denominator for incidence rate calculations | Measured in person-years, person-months, or person-days depending on study duration |
| Epidemiology | The scientific study of the distribution and determinants of health-related states or events in specified populations, and the application of this study to control health problems | Classic definition from Last's Dictionary of Epidemiology; incidence and prevalence are its foundational measures |
| Disease Surveillance | The ongoing systematic collection, analysis, and interpretation of health data essential to planning, implementing, and evaluating public health practice | Incidence and prevalence data are the primary outputs of disease surveillance systems like those maintained by the WHO and CDC |
| Morbidity | The state of being diseased or unhealthy; the frequency with which a disease appears in a population | Encompasses incidence, prevalence, and other measures of disease occurrence; contrasted with mortality |
| Mortality Rate | The frequency of deaths due to a specific cause in a defined population during a defined time period | Distinguished from case fatality rate, which uses diagnosed cases rather than total population as denominator |
| Attack Rate | A form of cumulative incidence used in outbreak contexts; the proportion of exposed individuals who develop disease during an epidemic | Secondary attack rate measures spread to household contacts; food-specific attack rates compare attack rates across different food exposures |
| Risk Ratio (Relative Risk) | The ratio of the cumulative incidence or incidence rate in an exposed group to that in an unexposed group | Measures the strength of association between a risk factor and disease; values greater than 1 indicate increased risk in the exposed group |
| Odds Ratio | The ratio of the odds of disease in an exposed group to the odds in an unexposed group | Used in case-control studies and logistic regression; approximates the risk ratio when disease prevalence is low (<10%) |
| Public Health | The science and art of preventing disease, prolonging life, and promoting health through organized efforts and informed choices of society, organizations, communities, and individuals | Incidence and prevalence are the primary quantitative tools public health uses to measure population health and evaluate interventions |
| Cohort Study | An observational study that follows a defined group of people over time to assess the development of disease or health outcomes | The primary design for calculating incidence rates and risk ratios; can be prospective or retrospective |
| Cross-sectional Study | A study that measures both exposure and disease status at a single point in time in a defined population | The primary design for calculating point prevalence; cannot establish temporal sequence between exposure and disease |
| Case Fatality Rate (CFR) | The proportion of people diagnosed with a disease who die from it within a specified follow-up period | Measures lethality, not population mortality; high CFR shortens disease duration and thereby reduces prevalence |
| Outbreak | The occurrence of more cases of a disease than expected in a given area or among a specific group of people over a particular period | Outbreak investigation relies on cumulative incidence (attack rate) as the primary measure of outbreak size and speed |
| Endemic | The constant presence and/or usual prevalence of a disease within a geographic area or population | Distinguished from epidemic (excess above expected) and pandemic (worldwide epidemic); prevalence is the natural measure of endemicity |
| Epidemic | The occurrence of more cases of disease than expected in a given area or population in a given period | Defined relative to the expected (endemic) level; recognized through incidence monitoring and surveillance |
| Disease Burden | The impact of a health problem on a population measured in terms of financial cost, mortality, morbidity, or other indicators | Prevalence is central to burden estimation; DALYs (disability-adjusted life years) combine mortality and morbidity into a single burden metric |
| Screening | The systematic testing of asymptomatic people in a defined population to detect disease at an early, treatable stage | Screening programs increase apparent prevalence by detecting previously undiagnosed cases; they may not change true prevalence or incidence |
Frequently Asked Questions
Key sources and further reading: WHO Diabetes Fact Sheet · CDC Influenza Weekly Surveillance · ECDC Seasonal Influenza Data · WHO COVID-19 Situation Reports · International Diabetes Federation — About Diabetes · Study Design Guide — Statistics Fundamentals · Statistics and Probability — Statistics Fundamentals · Gordis, L. (2014). Epidemiology (5th ed.). Elsevier. · Rothman, K.J., Greenland, S., Lash, T.L. (2008). Modern Epidemiology (3rd ed.). Lippincott Williams & Wilkins. · Last, J.M. (2001). A Dictionary of Epidemiology (4th ed.). Oxford University Press.